GERALD A. BRUNK - 20 Feb 2024 Form 4 Insider Report for enGene Holdings Inc. (ENGN)

Role: Director, 10%+ Owner
Signature: /s/ Gerald Brunk
Issuer symbol: ENGN
Transactions as of: 20 Feb 2024
Net transactions value: +$8,000,000
Form type: 4
Filing time: 21 Feb 2024, 16:20:30 UTC
Previous filing: 31 Oct 2023
Next filing: 18 Jun 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ENGN	Common Shares	Award	$6,449,650	+644,965	+185%	$10.00	993,651	20 Feb 2024	See Notes	F1, F7, F8
transaction	ENGN	Common Shares	Award	$1,550,350	+155,035	+185%	$10.00	238,851	20 Feb 2024	See Notes	F2, F7, F8
holding	ENGN	Common Shares						1,341,790	20 Feb 2024	See Notes	F3, F7, F8
holding	ENGN	Common Shares						44,647	20 Feb 2024	See Notes	F4, F7, F8
holding	ENGN	Common Shares						1,077,386	20 Feb 2024	See Notes	F5, F7, F8
holding	ENGN	Common Shares						152,974	20 Feb 2024	See Notes	F6, F7, F8

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These securities are held by Lumira Ventures IV, L.P. ("Lumira IV").
F2	These securities are held by Lumira Ventures IV (International), L.P. ("Lumira IV Int'l").
F3	These securities are held by Lumira Ventures III, L.P. ("Lumira III").
F4	These securities are held by Lumira Ventures III (International), L.P. ("Lumira III Int'l").
F5	These securities are held by Merck Lumira Biosciences Fund, L.P. ("Merck-Lumira").
F6	These securities are held by Merck Lumira Biosciences Fund (Quebec), L.P. ("Merck-Lumira B" and, together with Lumira III, Lumira III Int'l, Lumira IV, Lumira IV Int'l, and Merck-Lumira, the "Lumira Entities").
F7	Mr. Brunk is an executive officer of certain entities controlling and/or managing the Lumira Entities. Mr. Brunk disclaims beneficial ownership of the Common Shares held by the Lumira Entities, except to the extent of his pecuniary interest therein, if any. Lumira III and Lumira III Int'l are controlled by their general partner, Lumira Ventures III GP, L.P., and managed by Lumira Capital Investment Management Inc. ("Lumira Mgmt"). Lumira Ventures III GP, L.P. is controlled by its general partners, Lumira III GP Inc. and Lumira III GP Holdings Co. Lumira IV and Lumira IV Int'l are controlled by their general partner, Lumira IV GP 2020 Inc., and managed by Lumira Mgmt. Merck-Lumira and Merck-Lumira B are controlled by their general partner, Lumira Capital GP, L.P., and managed by Lumira Mgmt. (Continued in following footnote).
F8	(Continued from prior footnote). Lumira Capital GP, L.P. is controlled by its general partners, Lumira GP Inc. and Lumira GP Holdings Co. Mr. Brunk is an executive officer of each of Lumira III GP Inc., Lumira III GP Holdings Co., Lumira IV GP 2020 Inc., Lumira GP Inc., Lumira GP Holdings Co. and Lumira Mgmt. Each of Lumira III GP Inc., Lumira III GP Holdings Co., Lumira IV GP 2020 Inc., Lumira GP Inc., Lumira GP Holdings Co., Lumira Mgmt and Mr. Brunk may be deemed to beneficially own the securities held by the respective Lumira Entities, but each disclaims beneficial ownership except to the extent of their respective pecuniary interests therein, if any.